Homologous recombination repair gene mutations as a predictive biomarker for immunotherapy in patients with advanced melanomaZhixuan You, Changxuan You, Junfeng Ge et al.|Frontiers in Immunology|2022Cited by 16
Mefatinib as first-line treatment of patients with advanced non–small cell lung cancer harboring rare EGFR mutations.Pingli Wang, Kai Wang, Liming Cao et al.|Journal of Clinical Oncology|2022Cited by 0